
GV - Home
GV supports innovative founders moving the world forward. Introducing Learn More Faster: How to Find Your Bullseye Customer and Their Perfect Product
GV - Portfolio
We invest in innovative founders across industries and optimize for ideas that demand long-term relationships — ones where we can provide value across multiple stages and milestones.
GV - About
Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.
GV - Team
As computer scientists, engineers, and former entrepreneurs, we can get in the weeds with startup teams on technical challenges at any scale. And if we can't solve the problem or get the right answer, we leverage our relationships across …
GV - Press
GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology.
GV - News
Jan 11, 2024 · Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.
Jobs at GV Companies | GV
Explore career opportunities at GV Companies and join innovative teams driving progress across various industries.
GV guide to research - Medium
Jul 17, 2012 · This is one of the best collection of articles for user research in new product development that I’ve ever seen! I’d love to hear how you GV researchers think about user research in early stages of product Development vs mature, well running products - maybe an article idea for the future :)--
Design sprints: from Google Ventures to Google[x] - library.gv.com
Jul 9, 2014 · Learn about design sprints, created by GV design partner Jake Knapp.. Jake is joined by GV design partner Daniel Burka and Google staff designer Nadya Direkova. They talk about sprints and give examples of how sprints are used by …
GV - Robert Copeland
Robert A. Copeland, Ph.D., is a biomedical sciences entrepreneur with a strong track record of starting, building and leading successful drug discovery organizations. Copeland founded Accent Therapeutics in 2017 and served as its President & Chief Scientific Officer through 2024. He was formerly President of Research and Chief Scientific Officer of Epizyme, Inc. and before …